Insights & Perspectives

Filter by










Therapeutic Area / Research

Year Starting

Year Ending

Search Insights:
Showing 1 to 10 of 375
Filter by: Unfiltered

Blog Post | Mar 2, 2015

VEGF TKI adjuvant therapy in RCC does not ASSURE improved clinical outcomes

Oncology Conference Insight: ASCO GU --- Surgical resection is the primary treatment for patients with early-stage renal cell carcinoma (RCC) and can potentially be curative in up to 70% of cases. In many solid tumors, patients at high risk of recurrence are often treated with adjuvant (postsurgical) systemic therapy, with the idea being to eradicate any microscopic residual disease and thus decrease the likelihood of developing a local or metastatic recurrence.

Read more | Share

White Paper | Feb 26, 2015

Key Findings from the 2014 San Antonio Breast Cancer Symposium and the 2014 American Society of Hematology Annual Meetings

This issue of CancerNSightTM highlights significant information presented at ASH 2014, which took place December 6-9 in San Francisco, and SABCS 2014, which took place December 9-13 in San Antonio. Our goal is to provide our clients with the latest information presented at oncology meetings.

Read more | Share

Infographic | Feb 23, 2015

Living with a Rare Disease - Sjogren's Syndrome

Sjögren’s syndrome is a chronic autoimmune disease in which people’s white blood cells attack their moisture-producing glands. Hallmark symptoms are dry eyes, dry mouth, fatigue and joint pain.

Infographic | Feb 19, 2015

Colorectal Cancer

We have robust and clinically rich oncology data in all major regions of the world. We’ve highlighted a portion of colorectal cancer (CRC) data in Japan, Germany, China, Brazil and the United States from several of our best-in-class databases: National Health and Wellness Survey (NHWS), Epi Database® and CancerMPact®. Click on the tabs below to reveal data and our synopses.

White Paper | Feb 18, 2015

POV Insights: Prostate Cancer Epidemiology

Prostate cancer incidence rates fell from 2007 to 2011 in the United States. This decline in incidence may be attributable to changing practices in prostate-specific antigen (PSA) screening. We project a continued slight decline in incidence rates over next few years.

Read more | Share

Case Study | Feb 17, 2015

Time is of the Essence, Especially in Patient Care - Navigating the Regulatory Process in Brazil: Faster Approval and Desired Pricing, for New Oncology Drug

For oncology patients around the world, access to effective new therapies is a key factor for the successful treatment of their diseases. Expediting time to market, once safety and efficacy are demonstrated, is critical for both patients and pharmaceutical makers alike.

Read more | Share

White Paper | Feb 17, 2015

Caregiver Burden of Alzheimer's Disease in Japan

According to the Alzheimer's Association, Alzheimer's Disease (AD) is the most common form of dementia and can cause difficulties with behavior and memory. Research shows that households of patients with AD use significantly more healthcare resources and have higher direct healthcare costs than households without an AD patient.

Read more | Share

Case Study | Feb 12, 2015

Second Look Proves Successful: Innovative Methodology Demonstrates Superiority for New Diabetes Medicine

They say a second look can be game changing. That’s especially true for a top-15 pharmaceutical maker in Brazil that successfully challenged a Category II pricing designation for its new oral diabetes medicine thanks to a second look by Kantar Health’s Evidências.

Read more | Share

Datasheet | Feb 10, 2015

Systematic Literature Reviews

Datasheet: Systematic Literature Reviews --- Our team has extensive experience with systematic literature reviews (SLR), including the development of an optimal search strategy for clinical trials in the LILACS Database (Literatura Latino Americana e do Caribe em Ciências da Saúde), a major source for health information in Latin America.

Read more | Share

Case Study | Feb 6, 2015

Surviving a Knock-Out Blow: Challenging a Pricing Designation in Brazil

The ability to get up off the canvas after a perceived knock-out blow is a sign of greatness. What makes greatness easier to achieve for pharmaceutical companies is having a world-class coach in their corner.

Read more | Share
Page  < 123456789 >